GSK plc
GSK
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The compaā¦ read more
Healthcare
Drug ManufacturersāGeneral
46 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$51.51
Price-0.35%
-$0.18
1Y
Price
Market Cap
$103.200b
Large
Price/Earnings 3y Avg5y Avg
11.1x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in GBP.+33.6%
EBITDA Margin+5.2%
Net Profit Margin+26.2%
Free Cash Flow Margin+33.6%
EBITDA Margin+5.2%
Net Profit Margin+26.2%
Free Cash Flow MarginRevenue
$33.203b
+1.6%
1y CAGR+3.1%
3y CAGR+3.2%
5y CAGREarnings
$4.821b
-15.7%
1y CAGR+19.5%
3y CAGR-2.1%
5y CAGREPS
$2.37
-14.7%
1y CAGR+20.4%
3y CAGR-1.5%
5y CAGRBook Value
$17.073b
$61.365b
Assets$44.292b
Liabilities$18.128b
DebtDebt to Assets
29.5%
1.7x
Debt to EBITDAFree Cash Flow
$6.980b
+19.8%
1y CAGR+13.3%
3y CAGR+8.2%
5y CAGRNo items found.
Press Releases
Statements and updates from the company